These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 25826229)

  • 1. New clinical advances in immunotherapy for the treatment of solid tumours.
    Zavala VA; Kalergis AM
    Immunology; 2015 Jun; 145(2):182-201. PubMed ID: 25826229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CTLA-4 blockade: autoimmunity as treatment.
    Kapadia D; Fong L
    J Clin Oncol; 2005 Dec; 23(35):8926-8. PubMed ID: 16204008
    [No Abstract]   [Full Text] [Related]  

  • 3. Using antibodies in tumour immunotherapy.
    Schultes BC; Nicodemus CF
    Expert Opin Biol Ther; 2004 Aug; 4(8):1265-84. PubMed ID: 15268661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Principles and use of anti-CTLA4 antibody in human cancer immunotherapy.
    Peggs KS; Quezada SA; Korman AJ; Allison JP
    Curr Opin Immunol; 2006 Apr; 18(2):206-13. PubMed ID: 16464564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel antibodies targeting immune regulatory checkpoints for cancer therapy.
    Lee CS; Cragg M; Glennie M; Johnson P
    Br J Clin Pharmacol; 2013 Aug; 76(2):233-47. PubMed ID: 23701301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted cellular immunotherapy with bifunctional antibodies.
    Nelson H
    Cancer Cells; 1991 May; 3(5):163-72. PubMed ID: 1832553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-ErbB-2 monoclonal antibodies and ErbB-2-directed vaccines.
    Yip YL; Ward RL
    Cancer Immunol Immunother; 2002 Jan; 50(11):569-87. PubMed ID: 11807621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Evolving Role of Immune Checkpoint Inhibitors in Cancer Treatment.
    Pennock GK; Chow LQ
    Oncologist; 2015 Jul; 20(7):812-22. PubMed ID: 26069281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.
    Bodey B; Siegel SE; Kaiser HE
    Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immuno-regulatory antibodies for the treatment of cancer.
    Honeychurch J; Cheadle EJ; Dovedi SJ; Illidge TM
    Expert Opin Biol Ther; 2015 Jun; 15(6):787-801. PubMed ID: 25882106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor activity in melanoma and anti-self responses in a phase I trial with the anti-cytotoxic T lymphocyte-associated antigen 4 monoclonal antibody CP-675,206.
    Ribas A; Camacho LH; Lopez-Berestein G; Pavlov D; Bulanhagui CA; Millham R; Comin-Anduix B; Reuben JM; Seja E; Parker CA; Sharma A; Glaspy JA; Gomez-Navarro J
    J Clin Oncol; 2005 Dec; 23(35):8968-77. PubMed ID: 16204013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting T Cell Co-receptors for Cancer Therapy.
    Callahan MK; Postow MA; Wolchok JD
    Immunity; 2016 May; 44(5):1069-78. PubMed ID: 27192570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antibodies against cancer].
    Barriuso Feijóo J; Sundlov A; González Barón M
    Rev Clin Esp; 2004 Dec; 204(12):649-54. PubMed ID: 15710074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Anti-cancer monoclonal antibody].
    Sasaki S; Ishida T; Tsujisaki M; Imai K
    Nihon Rinsho; 2005 Apr; 63 Suppl 4():608-12. PubMed ID: 15861718
    [No Abstract]   [Full Text] [Related]  

  • 15. Immune Dysfunction in Non-Hodgkin Lymphoma: Avenues for New Immunotherapy-Based Strategies.
    Falchi L
    Curr Hematol Malig Rep; 2017 Oct; 12(5):484-494. PubMed ID: 28822058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bi-specific antibody therapy for the treatment of cancer.
    Withoff S; Helfrich W; de Leij LF; Molema G
    Curr Opin Mol Ther; 2001 Feb; 3(1):53-62. PubMed ID: 11249732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of antigen-specific and non-specific immunotherapy in the treatment of cancer.
    Monjazeb AM; Hsiao HH; Sckisel GD; Murphy WJ
    J Immunotoxicol; 2012; 9(3):248-58. PubMed ID: 22734880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapy of non-small cell lung cancer: report from an international experts panel meeting of the Italian association of thoracic oncology.
    Gridelli C; Ascierto PA; Barberis MC; Felip E; Garon EB; O'brien M; Senan S; Casaluce F; Sgambato A; Papadimitrakopoulou V; De Marinis F
    Expert Opin Biol Ther; 2016 Dec; 16(12):1479-1489. PubMed ID: 27650132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-tumor monoclonal antibodies in conjunction with β-glucans: a novel anti-cancer immunotherapy.
    Xiang D; Sharma VR; Freter CE; Yan J
    Curr Med Chem; 2012; 19(25):4298-305. PubMed ID: 22834812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in tumour immunotherapy.
    King J; Waxman J; Stauss H
    QJM; 2008 Sep; 101(9):675-83. PubMed ID: 18477644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.